Baywood  “making LIFE better”®
Home image Company Information image Contact Us image
Pressroom image International Inquiries image Online Partners image Become a Retailer image Become a Distributor image Become a Gold Leaf Retailer

Baywood Evolution™
Metabolic Burn Tropin EF™
Baywood Solutions®
Original Allergy Formula™
Original Snore Formula™
SuperJoints™

Fat Eliminator

Carb Eliminator™

Maximum Strength Carb Eliminator

Cal-Mag FIZZ™
Single-Dose Cranberry Extract™

CellXcite™

NEW! Magnesium FIZZ ™

Complete La Femme®
Breast & Balance™
Breast & Balance™ Lotion
Lip Maximizing Formula™
Vein Support Formula™
Complete Manicure™
MenoSoothe™
Baywood Purechoice®
Beta•s™
SAMe™
Relora®
Natto-Z™
NEW ! Diosmin™
 


Consumer Hotline: 1-800-418-7169

image image image

in the news

FOR: Baywood International, Inc.
CONTACT: Neil Reithinger, Chairman & C.E.O. (480) 951-3956
FOR IMMEDIATE RELEASE

General Nutrition Centers Nationwide to Launch Baywood Products

BusinessWire
Tuesday February 8 10:09am

SCOTTSDALE, Ariz.--(BW HealthWire)--Feb. 8, 2000--Baywood International, Inc. (OTCBB:BYWD) announced Tuesday that after the initial launch of its patented anti-snore product, "Dr. Harris' Original Snore Formula," into General Nutrition Centers (GNC) in the Dallas, Fort Worth and Houston areas of Texas in November, response and reorders have been more than anticipated.

This initial test has prompted GNC to approve the product for distribution nationwide beginning this month. As part of the continued implementation, Baywood has instituted a print and media campaign for the product to continuously support GNC.

"While the success of our test in Texas certainly assists us in building a solid working relationship with GNC, it underlines the importance of this product for consumers and its ability to alleviate snoring. The response and reorders for this product and others is what is most exciting for Baywood," stated Neil Reithinger, President & C.E.O.

The national roll-out into GNC will, at first, involve the top 800 stores across the country. Operating over 3,000 corporate and franchised stores in all 50 states and 20 foreign countries, GNC carries a full line of branded and private label nutritional products. Having been recently acquired by a Dutch company, (Royal) Numico, with operations in over 45 countries and which also produces a range of health products that help people improve their performances at every stage and for every lifestyle, GNC rebodys continuously poised to offer quality dietary supplements in the U.S. and around the globe.

"This further expansion into the retail channels allows us to more aggressively promote 'Dr. Harris' Original Snore Formula' while providing consumers a recognizable outlet to buy the product," Reithinger further stated.

Baywood is a consumer products company specializing in the development, marketing and distribution of natural-based products. The company's natural dietary supplement lines are marketed under the brand names, PURECHOICE(R) and SOLUTIONS(R). The company's products are distributed through independent and chain health food stores and pharmacies. Contact Baywood International, Inc. at 888/350-0799 for more information.

 

 

 

 

 

© 2002-08 Baywood International, Inc. All Rights Reserved. Updated on 04/08/2008
Home | Our Commitment To Change
Investor Relations | Terms Of Use | Webmaster

 

Consumer Hotline: 1-800-418-7169

news archive

Click here to view then entire archive for press releases about Baywood International, Inc.

ABOUT BAYWOOD:
Baywood International, Inc. is a nutraceutical company specializing in the development, marketing and distribution of its own proprietary brands under the names Baywood PURECHOICE® Baywood SOLUTIONS®, Baywood EVOLUTION and Complete La Femme®. The Company's products are distributed through independent and chain health food stores, pharmacies, grocery stores, and other direct-to-consumer channels both internationally and domestically. Contact Baywood International, Inc. at 1-888-350-0799 for more information visit www.bywd.com.

NOTICE:
These press releases may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Issuer’s expectations among other things are dependent upon general economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's Form 10-KSB’s and 10-QSB’s on file with the United States Securities and Exchange Commission.